Lacalle-Gonzalez, C.; Florez-Cespedes, M.; Sanz-Criado, L.; Ochieng’ Otieno, M.; Ramos-Muñoz, E.; Fernandez-Aceñero, M.J.; Ortega-Medina, L.; Garcia-Foncillas, J.; Martinez-Useros, J.
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. Biomedicines 2023, 11, 2812.
https://doi.org/10.3390/biomedicines11102812
AMA Style
Lacalle-Gonzalez C, Florez-Cespedes M, Sanz-Criado L, Ochieng’ Otieno M, Ramos-Muñoz E, Fernandez-Aceñero MJ, Ortega-Medina L, Garcia-Foncillas J, Martinez-Useros J.
DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. Biomedicines. 2023; 11(10):2812.
https://doi.org/10.3390/biomedicines11102812
Chicago/Turabian Style
Lacalle-Gonzalez, Carlos, Maria Florez-Cespedes, Lara Sanz-Criado, Michael Ochieng’ Otieno, Edurne Ramos-Muñoz, Maria Jesus Fernandez-Aceñero, Luis Ortega-Medina, Jesus Garcia-Foncillas, and Javier Martinez-Useros.
2023. "DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer" Biomedicines 11, no. 10: 2812.
https://doi.org/10.3390/biomedicines11102812
APA Style
Lacalle-Gonzalez, C., Florez-Cespedes, M., Sanz-Criado, L., Ochieng’ Otieno, M., Ramos-Muñoz, E., Fernandez-Aceñero, M. J., Ortega-Medina, L., Garcia-Foncillas, J., & Martinez-Useros, J.
(2023). DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer. Biomedicines, 11(10), 2812.
https://doi.org/10.3390/biomedicines11102812
